$1,650.00
We use our efficient integration-free, small molecule-based method to differentiate high-quality retinal pigment epithelium (RPE) precursor cells from human iPSCs. The differentiated RPE cells recapitulate the phenotype and functional parameters of primary and in vivo RPE cells.
We provide RPE cells differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from fibroblasts of an African American male donor. These cryopreserved, high-purity (>90%) cells express high levels of RPE biomarkers PMEL1, MITF, ZO-1, and RPE65.
These iPSC-differentiated RPE cells can be used as control lines to compare phenotype and functionality of patient-derived, genome-edited iPSC-derived RPE cells for drug screening applications.
| Table Header | Table Header |
|---|---|
|
Age |
Neonate |
|
Gender |
Male |
|
Ethnicity |
African American |
|
Tissue source |
Dermal fibroblasts |
|
Reprogramming method |
Episomal |
|
Culture conditions |
Feeder-free |
